Get started
Learn more about our CancerVision and RareVision tests, and get started today.
Select your test
CancerVision
$4,000
This test is for cancer patients with a solid tumor that was recently diagnosed, is recurring or metastatic, or that has not responded to treatments. The test package includes:
- Whole genome sequencing test and genetic mutation-linked treatment options
- Clinical trial matching based on the patient’s biomarkers and mutations, as well as the patient’s medical records
- Access to genetic counseling to help you understand the findings
RareVision
$2,400
This test is for patients or family members who are looking for a clearer diagnosis of a rare disease and/or an answer behind several rare disease symptoms. The test package includes:
- Whole genome sequencing test that covers both point and complicated mutations
- Genes associated with rare diseases from one of the most up-to-date databases
- Access to genetic counseling to help you understand the findings
Want to learn more first?
We know the road to diagnosis and effective treatment can feel frustrating. Our goal is for our tests to give you some peace of mind and more answers to empower you on your health journey.
Before you order a test, we invite you to learn more about our testing process and how the results are used.
If you have further questions, contact us at inquiry@inocras.com.
Patients
Learn more about how you can get the answers you need with our extensive genetic testing.
Providers
Learn how our tests can give you additional data, tools, and confidence in your medical decision making.
Researchers
Learn how you can maximize your research potential with precision WGS, curation, and interpretation.
Frequently asked questions
If you don’t see your question answered here, please contact us at inquiry@inocras.com.
What kind of samples are collected?
CancerVision requires tissue and blood samples. RareVision requires only a blood sample. Providers and researchers will receive detailed sample collection requirements in an instruction sheet once the test is ordered.
How are the test results shared?
Once a test is complete, the results will be shared with a genetic counselor, who will then share them with the patient directly. Patients will receive an email with a link and instructions to make an appointment with a genetic counselor.
How are the CancerVision and RareVision reports structured?
Inocras provides an easy-to-understand report, which highlights the most actionable findings that have implications for treatment options and other relevant findings related to genomic instability and germline analysis.
By focusing on these key areas, our report delivers the clinically critical and relevant information to healthcare providers and patients.